Should Biotech Be On The Critical List?
May 11, 2022 at 01:10 AM EDT
The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
